Navigation Links
New Symptom-free STD on the Rise in US and Australia

A new symptom-free sexually transmitted disease (STD) has surpassed Neisseria gonorrhea in prevalence among young adults in the US. In Australia too it is becoming a big menace, researchers say .

The new infection is named Mycoplasma genitalium and was first identified in the 1980s. It can cause inflammation of the urethra (the urinary passage from the bladder), in men, and inflammation of the cervix and the lining of the uterus in women, possibly leading to infertility.

In the current study, researchers at the University of Washington, Seattle, tested 1714 women and 1218 men between the ages of 18 and 27 years participating in Wave III of the National Longitudinal Study of Adolescent Health.

Results of the study are published in the American Journal of Public Health.

The investigators found Mycoplasma genitalium infection in 1.0 percent of the participants.

In contrast, the prevalence of gonorrhea was 0.4 percent. The prevalence of chlamydia infection was 4.2 percent.

The prevalence of Mycoplasma genitalium infection was 11 times higher among individuals living with a sexual partner, seven times higher among blacks and four times higher among those who use condoms during sex.

None of the genitalium-positive individuals had any discharge.

"Many M. genitalium infections are asymptomatic, like chlamydial infections,'' principal investigator Dr. Lisa Manhart said.

"However, unlike chlamydia, it is probably too soon to recommend widespread screening for M. genitalium.''

There are no commercial tests to detect the organism, she explained.

Furthermore, she and her colleagues note in their report that it is not clear "whether M. genitalium-infected persons require or benefit from treatment - and if so, what antimicrobial therapy should be recommended.''


'"/>




Page: 1

Related medicine news :

1. Australian Scientists Silence Cancer Gene
2. Australia earmarks $74 Million to Fight Bird Flu
3. Australian Government To Stockpile Anti-Bird Flu Drug Relenza
4. Obesity among The Poor in Australia.
5. Increase In Health Insurance Premium Likely In Australia
6. Australian Company Gets $10 million For Developing Skin Cancer Gel
7. Australian Health funds stand accused
8. Bird flu scare in Australia
9. Australia to Show Leniency towards U.S. Pharmaceutical Companies
10. Australia awaits US FDA reports on ADHD drugs
11. No booster vaccine For every fourth child in Australia

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Symptom free STD the Rise and Australia

(Date:12/2/2009)...nical trial presented today at the annual meeting ...) provide the first strong evidence of the benefit...se breasts who are at elevated risk for breast can...highly sensitive in depicting early breast cancer....nd in addition to mammography significantly improv...
(Date:12/1/2009)...st Medical Center in Oak Lawn, Ill. has become the... the first for Chicago’s south and southwest...l’s plans today (December 1) by the Illinois... Springfield, Ill. (Vocus) -...l. has become the state’s newest kidney tran...
(Date:12/1/2009)...ewswire/ -- Reportlinker.com announces that a new ...ue: ,, The Future of Central Nervous System Di...mpetitive Benchmarking, Product Pipeline and Deals...6814/The-Future-of-Central-Nervous-System-Diseases...ve-Benchmarking-Product-Pipeline-and-Deals-Analysi...
(Date:12/1/2009)...Newswire/ -- Reportlinker.com announces that a new...gue: ,, The Future of Monoclonal Antibodies - ..., Product Pipeline and Deals Analysis ,, http...oclonal-Antibodies---Market-Forecasts-to-2015-Comp...alysis.html ,, Summary ,, The author has...
(Date:12/1/2009)...re-USNewswire/ -- The Kerlan Jobe Orthopaedic Clin...greed to pay the United States $3 million to settl...rom HealthSouth Corporation, the Justice Departmen...ves allegations that HealthSouth paid kickbacks to...onations to the Kerlan Jobe Foundation, loan forgi...
Breaking Medicine News(10 mins):Health News:Annual screening with breast ultrasound or MRI could benefit some women 2Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 2Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 3Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 18Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 19Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 20Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 21Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 22Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12
...wledge that humans and other animals are able to v...he brain compares the images from each. But we can...s have been searching for how the brain accomplish...processes both the image from a single eye and als...
...m supported by the National Institutes of Health (... and Infectious Diseases (NIAID) has identified ch...erapies for schistosomiasis, a parasitic disease t.... , In their paper, researchers from Illinois Sta...
...est Prospective Trial to Examine Asthma Outcomes B..., RESEARCH TRIANGLE PARK, N.C. and PHILADELPHIA, ...showed that genetic differences at,the site of the...alation powder) or Serevent Diskus(R) (salmeterol ...
...0 cities waive co-pays if diabetic is "coached" by...y News) -- Diabetics taking part in the Diabetes T...y clinical and satisfaction indicators in the earl...ployer-based diabetes self-management program that...
... tumors from gaining a blood supply, studies sugge... -- The drug dopamine -- currently used to treat p...e, pituitary tumors and heart attack -- may also p...ment of new blood vessels, something that would sl...
...ch 14 Eli Lilly and Company,(NYSE: LLY ) today c...ticle,flat out wrong., The Times report in questio...Company trial that is underway and attempted to,in...he company makes the following statement:, -- Th...
Other Medicine News:Health News:Researchers discover second depth-perception method in brain 2Health News:Scientists identify new leads for treating parasitic worm disease 2Health News:Scientists identify new leads for treating parasitic worm disease 3Health News:GSK Data Suggests Efficacy of Advair(R) and Serevent(R) is Not Impacted by Genetic Profile 2Health News:GSK Data Suggests Efficacy of Advair(R) and Serevent(R) is Not Impacted by Genetic Profile 3Health News:GSK Data Suggests Efficacy of Advair(R) and Serevent(R) is Not Impacted by Genetic Profile 4Health News:Self-Management Program Helps Diabetics 2Health News:Parkinson's Drug May Fight Cancer 2Health News:Statement from Eli Lilly and Company: Response to Today's New York Times Article, 'Lilly E-Mail Discussed Off-Label Drug Use' 2Health News:Statement from Eli Lilly and Company: Response to Today's New York Times Article, 'Lilly E-Mail Discussed Off-Label Drug Use' 3Health News:Statement from Eli Lilly and Company: Response to Today's New York Times Article, 'Lilly E-Mail Discussed Off-Label Drug Use' 4Health News:Statement from Eli Lilly and Company: Response to Today's New York Times Article, 'Lilly E-Mail Discussed Off-Label Drug Use' 5
(Date:12/1/2009)... -- Reportlinker.com announces that a new market r..., The Future of Oncology Therapeutics - Market Fo... Pipeline and Deals Analysis ,, http://www.re...rapeutics---Market-Forecasts-to-2015-Competitive-B...ml ,, Summary ,, The author has released ...
(Date:12/1/2009)...ation reduction in cardiac CT scans ,, CHICAGO,..., a radiologist from Fairfax Radiological Consulta...findings of a study that shows a 90 percent reduct...ived from CT scans compared to scans performed two...dy to the annual meeting of the Radiological Socie...
(Date:12/1/2009)...c. 1 Former New Jersey A...ted when his radiotherapy treatment sessions for p... to less than five. Midway through his course of ... Cancer Center acquired the region,s first Rapi...dical Systems (NYSE: VAR ), making it possible f...
Breaking Medicine Technology:Reportlinker Adds The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Reportlinker Adds The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Radiation Reduction in Heart CT Scans Reported in Study 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 3Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 4Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 5Many Health Care Workers May Shun Swine Flu Shot 55387 1Many Health Care Workers May Shun Swine Flu Shot 55387 2Danaher to Present at Morgan Stanley Global Industrials Conference 55383 1Waste Management and Terrabon Announce Investment Agreement for Waste To Fuel Conversion Technology 13694 1Waste Management and Terrabon Announce Investment Agreement for Waste To Fuel Conversion Technology 13694 2Waste Management and Terrabon Announce Investment Agreement for Waste To Fuel Conversion Technology 13694 3Waste Management and Terrabon Announce Investment Agreement for Waste To Fuel Conversion Technology 13694 4
...for PTC124 - , , SOUTH PLAINFIELD, N.J., Feb. 3 ...it has successfully completed patient enrollment o... with nonsense mutation Duchenne and Becker muscul...wo months ahead of schedule. The company also ann...ic name, ataluren. , , (Logo: http://www.newsco...
...3 Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ) t...hip discussions regarding R788 until after results...ilable. The company expects that,these results, ...ill,substantially further the understanding of R78...nomics in a possible deal. The company expects to ...
Other Medicine Technology:PTC Therapeutics Completes Enrollment of Pivotal Trial in Muscular Dystrophy 2PTC Therapeutics Completes Enrollment of Pivotal Trial in Muscular Dystrophy 3PTC Therapeutics Completes Enrollment of Pivotal Trial in Muscular Dystrophy 4PTC Therapeutics Completes Enrollment of Pivotal Trial in Muscular Dystrophy 5Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results 2Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results 3Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results 4Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results 5
LES Identification Accessories Kit
pHix Strips
...se pH catheters are efficient, economical, elimina...er patient comfort during the test period., ,NOTE...gned to use temperature correction factors that al...temperature correction factors for Bravo capsules ...
... of online quality control with Quantrol Online. I...and peer group statistics right at your fingertips... internet based format for review of quality contr...ntrol data mangement systems with long report turn...
Medicine Products: